Absence of GluD2 Antibodies in Patients With Opsoclonus-Myoclonus Syndrome.
Mar Petit-PedrolMar GuaspThaís ArmangueCinzia LavarinoAndrés Morales La MadridAlbert SaizFrancesc GrausJosep O DalmauPublished in: Neurology (2020)
We did not find GluD2-ab in a large cohort of patients with OMS. GluD2-ab should not be considered diagnostic biomarkers of OMS.
Keyphrases